Heavy chain disease
(Redirected from Immunoproliferative small intestinal disease)
Heavy chain disease is a rare form of B-cell lymphoproliferative disorder characterized by the production of incomplete immunoglobulin heavy chains without associated light chains. These abnormal heavy chains are unable to form functional antibodies and are typically found in the blood, urine, and tissues of affected individuals.
Etiology[edit | edit source]
The exact cause of heavy chain disease is unknown. However, it is believed to be associated with chronic immune system stimulation, such as that which occurs in chronic infections or autoimmune diseases. Some studies have also suggested a possible genetic component.
Types[edit | edit source]
There are three recognized types of heavy chain disease, each named for the type of heavy chain involved:
- Alpha heavy chain disease (α-HCD): Also known as Immunoproliferative Small Intestinal Disease (IPSID), this is the most common type of heavy chain disease. It primarily affects the small intestine and is most common in the Mediterranean region, the Middle East, and North Africa.
- Gamma heavy chain disease (γ-HCD): Also known as Franklin's disease, this type primarily affects the blood and lymph nodes. It is the second most common type of heavy chain disease.
- Mu heavy chain disease (μ-HCD): This is the rarest type of heavy chain disease and primarily affects the blood and bone marrow.
Symptoms[edit | edit source]
The symptoms of heavy chain disease vary depending on the type and the organs affected. Common symptoms include weight loss, fatigue, and weakness. In α-HCD, symptoms may also include diarrhea and abdominal pain. In γ-HCD and μ-HCD, symptoms may include swollen lymph nodes and anemia.
Diagnosis[edit | edit source]
Diagnosis of heavy chain disease is based on the detection of abnormal heavy chains in the blood or urine using immunoelectrophoresis or immunofixation. Additional tests, such as a biopsy of affected tissue, may also be performed.
Treatment[edit | edit source]
Treatment of heavy chain disease is primarily aimed at controlling the underlying lymphoproliferative disorder. This may involve chemotherapy, immunotherapy, or stem cell transplantation. The prognosis varies depending on the type of heavy chain disease and the individual's overall health.
See also[edit | edit source]
- Immunoglobulin heavy chain
- Lymphoproliferative disorders
- Immunoproliferative Small Intestinal Disease
- Franklin's disease
This rare disease-related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD